Results 301 to 310 of about 43,593 (324)

Antibody reactivity against trophoblast and trophoblast products

Journal of Reproductive Immunology, 1985
Sensitive immunoassays have been applied to WHO reference bank sera from fertile and infertile women in order to assess any naturally occurring antibody reactive with isolated human placental trophoblast membranes or two separate trophoblast protein products (hCG and SP1).
P M, Johnson, H M, Cheng, V C, Stevens, P, Matangkasombut   +3 more
openaire   +2 more sources

Gestational Trophoblastic Disease

Obstetrics & Gynecology, 2006
This review summarizes the primary management of molar pregnancies, surveillance after evacuation, and the evaluation and management of malignant gestational trophoblastic neoplasia (GTN). Most women with gestational trophoblastic disease can be successfully managed with preservation of their normal reproductive function.
openaire   +2 more sources

[Trophoblastic diseases].

Nederlands tijdschrift voor geneeskunde, 2008
Contains fulltext : 69202.pdf (Publisher’s version ) (Closed access)
Kate-Booij, M.J. ten, Lok, C.A., Verheijen, R.H., Massuger, L.F.A.G., Trommel, N.E. van   +4 more
openaire   +2 more sources

Gestational trophoblastic neoplasms

Gynecologic Oncology, 1974
A review of the classification, biological behavior, clinical diagnosis, and treatment of gestational trophoblastic neoplasms is presented. The events which followed the utilization of chemotherapy as a successful means of therapy are included. Especially important has been the recent recognition that high risk patients, i.e., patients with HCG titers ...
R D, Hilgers, J L, Lewis
openaire   +2 more sources

Gestational Trophoblastic Disease

Radiologic Clinics of North America, 2013
Imaging plays a crucial role in diagnosis and management of gestational trophoblastic disease. Ultrasonography is the initial investigation of choice for the diagnosis. Pelvic magnetic resonance (MR) imaging is used as a problem-solving tool for assessment of degree of local invasion.
Alampady K P, Shanbhogue, Neeraj, Lalwani, Christine O, Menias   +2 more
openaire   +2 more sources

Gestational trophoblastic disease

The Lancet, 2010
Gestational trophoblastic disease encompasses a range of pregnancy-related disorders, consisting of the premalignant disorders of complete and partial hydatidiform mole, and the malignant disorders of invasive mole, choriocarcinoma, and the rare placental-site trophoblastic tumour.
Michael J, Seckl, Neil J, Sebire, Ross S, Berkowitz   +2 more
openaire   +2 more sources

Gestational Trophoblastic Neoplasms

Journal of Obstetric, Gynecologic & Neonatal Nursing, 1986
Gestational trophoblastic neoplasms have evolved from one of the most rapidly fatal malignancies to potentially one of the most curable, but these diseases have devastating emotional effects on the victims. Etiology, epidemiology, pathophysiology, diagnosis, and medical treatment are reviewed.
S M, Celeste, M D, Smith
openaire   +2 more sources

Gestational trophoblastic diseases

International Journal of Gynecology & Obstetrics, 2003
In 1991, FIGO added non-surgical-pathologic prognostic risk factors to the classic anatomical staging system. These include urinary hCG levels >100000mIU/ml and/or serum b-hCG >40000mIU/ml and the duration of an antecedent pregnancy being >6 months. Since gestational trophoblastic diseases (GTD) have a very high cure rate in virtually all patients, the
Ngan, H. Y, ODICINO, Franco, Maisonneuve, P, Beller, U, Benedet, J. L, Heintz, A. P, PECORELLI, Sergio, Creasman, W. T.   +7 more
openaire   +5 more sources

Trophoblastic Disease

1992
Y, Tomoda, T, Ishizuka, S, Goto, Y, Furuhashi   +3 more
openaire   +2 more sources

Trophoblastic Neoplasms

New England Journal of Medicine, 1965
openaire   +2 more sources